img

Global Adjuvanted Influenza Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Adjuvanted Influenza Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

An adjuvanted influenza vaccine is a type of influenza vaccine that has a substance called an "adjuvant" added during the vaccine preparation process. Adjuvant is a substance that can enhance the immune response. It can improve the response of the immune system to vaccine components (such as viral antigens) after vaccination, thereby increasing the effect of immune protection.
Global Adjuvanted Influenza Vaccine market is projected to reach US$ 2176.1 million in 2029, increasing from US$ 952.3 million in 2022, with the CAGR of 12.2% during the period of 2024 to 2029. Demand from Public Sector and Private Sector are the major drivers for the industry.
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Adjuvanted Influenza Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL
Segment by Type
Vial
Prefilled

Segment by Application


Public Sector
Private Sector

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Adjuvanted Influenza Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Adjuvanted Influenza Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Adjuvanted Influenza Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Adjuvanted Influenza Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Adjuvanted Influenza Vaccine introduction, etc. Adjuvanted Influenza Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Adjuvanted Influenza Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Adjuvanted Influenza Vaccine Market Overview
1.1 Adjuvanted Influenza Vaccine Product Overview
1.2 Adjuvanted Influenza Vaccine Market Segment by Type
1.2.1 Vial
1.2.2 Prefilled
1.3 Global Adjuvanted Influenza Vaccine Market Size by Type
1.3.1 Global Adjuvanted Influenza Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Adjuvanted Influenza Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Adjuvanted Influenza Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Adjuvanted Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Adjuvanted Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Adjuvanted Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Adjuvanted Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Adjuvanted Influenza Vaccine Sales Breakdown by Type (2018-2024)
2 Global Adjuvanted Influenza Vaccine Market Competition by Company
2.1 Global Top Players by Adjuvanted Influenza Vaccine Sales (2018-2024)
2.2 Global Top Players by Adjuvanted Influenza Vaccine Revenue (2018-2024)
2.3 Global Top Players by Adjuvanted Influenza Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Adjuvanted Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Adjuvanted Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Adjuvanted Influenza Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Adjuvanted Influenza Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adjuvanted Influenza Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Adjuvanted Influenza Vaccine Market
2.8 Key Manufacturers Adjuvanted Influenza Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Adjuvanted Influenza Vaccine Status and Outlook by Region
3.1 Global Adjuvanted Influenza Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Adjuvanted Influenza Vaccine Historic Market Size by Region
3.2.1 Global Adjuvanted Influenza Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Adjuvanted Influenza Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Adjuvanted Influenza Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Adjuvanted Influenza Vaccine Forecasted Market Size by Region
3.3.1 Global Adjuvanted Influenza Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Adjuvanted Influenza Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Adjuvanted Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Adjuvanted Influenza Vaccine by Application
4.1 Adjuvanted Influenza Vaccine Market Segment by Application
4.1.1 Public Sector
4.1.2 Private Sector
4.2 Global Adjuvanted Influenza Vaccine Market Size by Application
4.2.1 Global Adjuvanted Influenza Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Adjuvanted Influenza Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Adjuvanted Influenza Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Adjuvanted Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Adjuvanted Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Adjuvanted Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Adjuvanted Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Adjuvanted Influenza Vaccine Sales Breakdown by Application (2018-2024)
5 North America Adjuvanted Influenza Vaccine by Country
5.1 North America Adjuvanted Influenza Vaccine Historic Market Size by Country
5.1.1 North America Adjuvanted Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Adjuvanted Influenza Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Adjuvanted Influenza Vaccine Sales in Value by Country (2018-2024)
5.2 North America Adjuvanted Influenza Vaccine Forecasted Market Size by Country
5.2.1 North America Adjuvanted Influenza Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Adjuvanted Influenza Vaccine Sales in Value by Country (2024-2029)
6 Europe Adjuvanted Influenza Vaccine by Country
6.1 Europe Adjuvanted Influenza Vaccine Historic Market Size by Country
6.1.1 Europe Adjuvanted Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Adjuvanted Influenza Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Adjuvanted Influenza Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Adjuvanted Influenza Vaccine Forecasted Market Size by Country
6.2.1 Europe Adjuvanted Influenza Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Adjuvanted Influenza Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Adjuvanted Influenza Vaccine by Region
7.1 Asia-Pacific Adjuvanted Influenza Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Adjuvanted Influenza Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Adjuvanted Influenza Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Adjuvanted Influenza Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Adjuvanted Influenza Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Adjuvanted Influenza Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Adjuvanted Influenza Vaccine Sales in Value by Region (2024-2029)
8 Latin America Adjuvanted Influenza Vaccine by Country
8.1 Latin America Adjuvanted Influenza Vaccine Historic Market Size by Country
8.1.1 Latin America Adjuvanted Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Adjuvanted Influenza Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Adjuvanted Influenza Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Adjuvanted Influenza Vaccine Forecasted Market Size by Country
8.2.1 Latin America Adjuvanted Influenza Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Adjuvanted Influenza Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Adjuvanted Influenza Vaccine by Country
9.1 Middle East and Africa Adjuvanted Influenza Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Adjuvanted Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Adjuvanted Influenza Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Adjuvanted Influenza Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Adjuvanted Influenza Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Adjuvanted Influenza Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Adjuvanted Influenza Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CSL
10.1.1 CSL Company Information
10.1.2 CSL Introduction and Business Overview
10.1.3 CSL Adjuvanted Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 CSL Adjuvanted Influenza Vaccine Products Offered
10.1.5 CSL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Adjuvanted Influenza Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Adjuvanted Influenza Vaccine Industrial Chain Analysis
11.4 Adjuvanted Influenza Vaccine Market Dynamics
11.4.1 Adjuvanted Influenza Vaccine Industry Trends
11.4.2 Adjuvanted Influenza Vaccine Market Drivers
11.4.3 Adjuvanted Influenza Vaccine Market Challenges
11.4.4 Adjuvanted Influenza Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Adjuvanted Influenza Vaccine Distributors
12.3 Adjuvanted Influenza Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Vial
Table 2. Major Company of Prefilled
Table 3. Global Adjuvanted Influenza Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Adjuvanted Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global Adjuvanted Influenza Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Adjuvanted Influenza Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Adjuvanted Influenza Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Adjuvanted Influenza Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Adjuvanted Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 10. Global Adjuvanted Influenza Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Adjuvanted Influenza Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Adjuvanted Influenza Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Adjuvanted Influenza Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Adjuvanted Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America Adjuvanted Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Adjuvanted Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe Adjuvanted Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Adjuvanted Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Adjuvanted Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Adjuvanted Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America Adjuvanted Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Adjuvanted Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Adjuvanted Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Adjuvanted Influenza Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global Adjuvanted Influenza Vaccine Sales Share by Company (2018-2024)
Table 26. Global Adjuvanted Influenza Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Adjuvanted Influenza Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Adjuvanted Influenza Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Adjuvanted Influenza Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Adjuvanted Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adjuvanted Influenza Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Adjuvanted Influenza Vaccine Market
Table 33. Key Manufacturers Adjuvanted Influenza Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Adjuvanted Influenza Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Adjuvanted Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global Adjuvanted Influenza Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Adjuvanted Influenza Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Adjuvanted Influenza Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Adjuvanted Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Adjuvanted Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 42. Global Adjuvanted Influenza Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Adjuvanted Influenza Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Adjuvanted Influenza Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Adjuvanted Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Adjuvanted Influenza Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Adjuvanted Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 48. Global Adjuvanted Influenza Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Adjuvanted Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Adjuvanted Influenza Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Adjuvanted Influenza Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Adjuvanted Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. Global Adjuvanted Influenza Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Adjuvanted Influenza Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Adjuvanted Influenza Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Adjuvanted Influenza Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Adjuvanted Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 58. North America Adjuvanted Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Adjuvanted Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 60. Europe Adjuvanted Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Adjuvanted Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Adjuvanted Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Adjuvanted Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Latin America Adjuvanted Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Adjuvanted Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Adjuvanted Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America Adjuvanted Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Adjuvanted Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 72. North America Adjuvanted Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Adjuvanted Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe Adjuvanted Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Adjuvanted Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 80. Europe Adjuvanted Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Adjuvanted Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Adjuvanted Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Adjuvanted Influenza Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Adjuvanted Influenza Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Adjuvanted Influenza Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Adjuvanted Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Adjuvanted Influenza Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Adjuvanted Influenza Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Adjuvanted Influenza Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Adjuvanted Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Adjuvanted Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Adjuvanted Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Adjuvanted Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Adjuvanted Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Adjuvanted Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Adjuvanted Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Adjuvanted Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. CSL Company Information
Table 108. CSL Introduction and Business Overview
Table 109. CSL Adjuvanted Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. CSL Adjuvanted Influenza Vaccine Product
Table 111. CSL Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Adjuvanted Influenza Vaccine Market Trends
Table 115. Adjuvanted Influenza Vaccine Market Drivers
Table 116. Adjuvanted Influenza Vaccine Market Challenges
Table 117. Adjuvanted Influenza Vaccine Market Restraints
Table 118. Adjuvanted Influenza Vaccine Distributors List
Table 119. Adjuvanted Influenza Vaccine Downstream Customers
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Adjuvanted Influenza Vaccine Product Picture
Figure 2. Global Adjuvanted Influenza Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Adjuvanted Influenza Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Adjuvanted Influenza Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Vial
Figure 6. Global Vial Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Prefilled
Figure 8. Global Prefilled Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Adjuvanted Influenza Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Adjuvanted Influenza Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Adjuvanted Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Adjuvanted Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Adjuvanted Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Adjuvanted Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Adjuvanted Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Adjuvanted Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Adjuvanted Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Adjuvanted Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Adjuvanted Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Adjuvanted Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Adjuvanted Influenza Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Adjuvanted Influenza Vaccine Revenue in 2022
Figure 23. Adjuvanted Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Public Sector
Figure 25. Global Public Sector Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Private Sector
Figure 27. Global Private Sector Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Adjuvanted Influenza Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Adjuvanted Influenza Vaccine Sales Market Share by Application in 2022 & 2029
Figure 30. North America Adjuvanted Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Adjuvanted Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Adjuvanted Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Adjuvanted Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Adjuvanted Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Adjuvanted Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Adjuvanted Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Adjuvanted Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Adjuvanted Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Adjuvanted Influenza Vaccine Manufacturing Cost Structure
Figure 41. Adjuvanted Influenza Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed